Philadelphia, Pennsylvania--(Newsfile Corp. - April 26, 2023) - Kaskela Law LLC announces that it is investigating Alignment Healthcare, Inc. ("Alignment") (NASDAQ: ALHC) on behalf of the Company's investors.
Since January 2023, shares of Alignment's common stock have declined in value from a trading price of approximately $12.50 per share to a current trading price of less than $7.00 per share, a cumulative decline of approximately 45% in value.
The investigation seeks to determine whether Alignment and/or the company's representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to Alignment investors, thereby causing investor losses.
Alignment stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/alignment-healthcare/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
Kaskela Law LLC Announces Shareholder Investigation of Alignment Healthcare, Inc. (NASDAQ: ALHC) and Encourages Investors to Contact the Firm for Additional Information
Philadelphia, PA
April 26, 2023
Kaskela Law LLC announces that it is investigating Alignment Healthcare, Inc. ("Alignment") (NASDAQ: ALHC) on behalf of the Company's shareholders.
Since January 2023, shares of Alignment's common stock have declined in value from a trading price of approximately $12.50 per share to a current trading price of less than $5.50 per share, a cumulative decline of over 56% in value.
The investigation seeks to determine whether Alignment and/or the company's representatives violated the securities laws by issuing false and/or misleading statements, or by failing to disclose material information, to Alignment shareholders, thereby causing investor losses.
Alignment stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/alignment-healthcare/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/163769
Published by: Newsfile Corp .